ArticleBlood2017

Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies.

Maureen C Ryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.